Blog / Legal News and Product Recalls

Monsanto Fakes Research to Keep the Money Rolling In While Poisoning the Public

Monsanto is in the news again for all the wrong reasons. Most recently, a federal judge in San Francisco unsealed Monsanto’s internal emails and emails to and from federal regulators indicating that Monsanto ghostwrote research on its controversial Roundup weed killer compounds, then passed it off as research from independent academics. These communications also show that Monsanto worked with senior officials at the EPA to quash a review of glyphosphate, Roundup’s main toxic ingredient, by the U.S. Department of Health and Human Services. Among the email gems was those written by a Monsanto executive, giving his colleagues the green light to ghostwrite glyphosate research and then hire academics to put their names on the papers as Monsanto had done in the past, saying "e would be keeping the cost down by us doing the writing and they would just edit & sign their names so to speak.” Another one from a Monsanto executive, to an EPA official who was heading the cancer risk evaluation of Roundup, stated that "If I can kill this, I should get a medal." The Roundup evaluation never happened. The point of such efforts was undoubtedly to mislead the American public into believing that Round-Up won’t give them cancer, despite a host of truly independent research suggesting that glyphosphate is a probable human carcinogen. In addition to its potential cancer-causing properties, Roundup has also been linked to a host of other health issues such as ADHD, Alzheimer's disease, kidney disease, liver disease, reproductive problems and birth defects, as well as environmental impacts, such as the record decline of monarch butterflies to the point of extinction. A 2014 study conducted by the U.S. Geological Survey detected the presence of Roundup in 75 percent of air and rainfall test samples taken from the Mississippi Delta, a fertile agricultural region. The International Agency for Research on Cancer (“IARC”) published their monograph on glyphosate, the main ingredient in Roundup, and classified it as "probably carcinogenic in humans" (category 2A) based on epidemiological studies, animal studies, and in vitro studies. IARC is a division of the World Health Organization, and an independent body of scientists that adheres to the strictest scientific methodology in coming to its determinations regarding carcinogens. Moreover, a case-controlled study  published in 1999 by Swedish scientists Lennart Hardell and Mikael Eriksson showed that non-hodgkin’s lymphoma (NHL) is linked to exposure to a range of pesticides and herbicides, including glyphosate. Prior to the 1940s, non-hodgkin’s lymphoma was one of the world’s rarest cancers. Now it is one of the most common. Between 1973 and 1991, the incidence of non-hodgkin’s lymphoma increased at the rate of 3.3 percent per year in the United States, making it the third fastest-growing cancer. In Sweden, the incidence of NHL has increased at the rate of 3.6 percent per year in men and 2.9 percent per year in women since 1958. Fake news is bad enough, but fake science represents an entirely different level of deceit. People have the right to choose food that has been produced without poisonous herbicides. Monsanto has repeatedly fought against truthful labeling regarding the food we are being sold, but its willingness to fake scientific studies represents a new low. If you or your loved ones have contracted non-Hodgkin’s lymphoma and were exposed to Roundup or other glyphosphate-containing products, you should contact a qualified attorney to explore your rights.
Posted in:

Related Posts

Hospital sign pointing to the Emergency Room and Main Entrance outside a medical building

$3.77 Million in Medical Malpractice Case Against Wheeling Doctor and PA

WHEELING, WV / PITTSBURGH, PA — An Ohio County, West Virginia jury has returned a $3.77 Million verdict in a medical malpractice case against a doctor and a physician’s assistant at WVU Medicine Wheeling Hospital. Following a four-day trial, the jury found both Dr. Barry Mitchell and Physician’s Assistant Michelle Porembka negligent in their medical care of 64 year old Julie Daley when she presented with abdominal complaints at the Wheeling Hospital emergency room in June 2022. As a result of the medical care providers’ failure to timely and properly treat her condition, Daley ultimately sustained a perforated colon along with necrosis which ultimately lead to her needing to have a permanent colostomy. The jury found that the conduct of both Mitchell and Poermbka fell below the standard of care for medical care providers in their field and that their negligence proximately caused injuries and damages to Mrs. Daley.  Daley was represented at trial by Geoff Brown and Tyler Smith of the Wheeling law firm of Bordas & Bordas. Following the verdict, Smith commented, “We are pleased that the jury recognized that this should not have happened to Julie Daley and that they compensated her for the life-long effects that she will have as a result of the negligence of the medical providers.” Mark Robinson and David Givens of Flaherty, Sensabaugh, and Bonasso represented the medical providers at trial.  Circuit Court Judge Jason Cuomo presided over the case. Brown stated “Our practice is based upon fighting for justice for people who have been injured or wronged by others.  Helping others is at the root of everything that we do and we are glad that we were able to help Julie and her family obtain a measure of justice through this case and this result.” About Bordas & Bordas Founded in 1985, Bordas & Bordas Attorneys PLLC has earned a reputation as one of the region’s premier personal injury and plaintiff litigation law firms. With offices in Wheeling and Moundsville, West Virginia; Pittsburgh, Pennsylvania; and St. Clairsville, Ohio, the firm represents clients in cases involving automobile and trucking accidents, medical malpractice, workplace injuries, nursing home negligence, product liability, wrongful death, insurance bad faith, and more. The firm operates on a contingency fee basis (clients pay only if there is a recovery) and offers free initial consultations. Rooted in its core values of experience, family, community, and results, Bordas & Bordas continues to stand as a trusted advocate for individuals and families across the Ohio Valley and beyond. Visit www.bordaslaw.com for more information.

The Pennsylvania Superior Court Analyzes the Federal Public Readiness and Emergency Preparedness Act in Denying Defendants’ Motion for Judgment on the Pleadings

The Pennsylvania Superior Court Analyzes the Federal Public Readiness and Emergency Preparedness Act in Denying Defendants’ Motion for Judgment on the Pleadings

The Pennsylvania Superior Court Analyzes the Federal Public Readiness and Emergency Preparedness Act in Denying Defendants’ Motion for Judgment on the Pleadings In Boyle v. Meyer, 2025 PA Super 198 (September 9, 2025), the Pennsylvania Superior Court denied a physical therapy company’s motion for judgment on the pleadings based on the immunity provisions contained in the federal Public Readiness and Emergency Preparedness Act (PREP Act). Background of the Case Plaintiff Boyle required physical therapy following open-heart surgery. To minimize the risk of contracting COVID-19, he arranged for OSPTA Home Care to provide in-home services. On November 8, 2020, physical therapist Meyer arrived without gloves, a face shield, or a proper mask — only wearing a thin, disposable surgical mask. Meyer also shook Boyle’s hand without gloves, did not wash her hands before treatment, and performed therapy as usual. Days later, OSPTA informed Boyle that Meyer had tested positive for COVID-19. Boyle soon developed symptoms, was hospitalized for ten days, and continued to suffer complications five months later. Boyle sued OSPTA and Meyer, alleging: Meyer was negligent in failing to wear proper personal protective equipment (PPE). Meyer exposed him to unreasonable risk and performed therapy despite known exposure. OSPTA failed to properly train and supervise Meyer and implement safeguards to prevent the virus’s spread. Defendants’ Motion and PREP Act Defense In response, Defendants admitted Meyer was not wearing gloves or a face shield but stated she wore a surgical mask and used hand sanitizer earlier in the day. They argued they were immune from liability under the Public Readiness and Emergency Preparedness Act, 42 U.S.C. §§ 247d-6d, 247d-6e. Defendants asserted that they met all four requirements for immunity: Public health emergency – The COVID-19 pandemic triggered PREP Act protections. Covered persons – They qualified as both “program planners” and “qualified persons” under the Act. Covered countermeasure – Meyer’s “thin, disposable surgical mask” was a device authorized for emergency use by the FDA. Causal relationship – Meyer’s use of the mask had a causal connection to Boyle’s COVID-19 claim. The trial court denied their motion for judgment on the pleadings. Superior Court’s Analysis On appeal, the Superior Court found several factual disputes that prevented judgment for the Defendants. Specifically: It was unclear whether Meyer’s surgical mask qualified as a “covered countermeasure.” The pleadings did not conclusively establish that the Defendants were “covered persons.” Even if both were true, PREP Act immunity applies only to the use or administration of a covered countermeasure — not to its non-use. Citing Hampton v. California, 83 F.4th 754 (9th Cir. 2023), the Court noted that the PREP Act shields defendants from claims related to administering a covered measure, but not from claims alleging failure to administer one. Because Boyle’s complaint focused on the failure to use proper PPE, inadequate screening, and lack of training, his claims fell outside the scope of federal immunity. Conclusion The Superior Court concluded that the PREP Act did not preempt Boyle’s state-law negligence claims, affirming the trial court’s denial of the motion for judgment on the pleadings. The full opinion in Boyle v. Meyer, 2025 PA Super 198 (September 9, 2025), is available on the Pennsylvania Judiciary website. To learn more about legal issues surrounding immunity and negligence in Pennsylvania courts, visit our post on how the PA Superior Court reviews evidentiary challenges in medical cases.

Lead Risk Prompts Nationwide Recall of Ground Cinnamon

Lead Risk Prompts Nationwide Recall of Ground Cinnamon

Lead Risk Prompts Nationwide Recall of Ground Cinnamon The U.S. Food and Drug Administration (FDA) has issued a nationwide recall of 12 ground cinnamon brands after testing revealed elevated levels of lead. Roughly 21,690 units were sold through retailers like Dollar Tree and Save-A-Lot before being pulled from shelves. Consumers are urged to immediately throw away any affected products and avoid purchasing them until further notice. See the official FDA recall notice. Why This Recall Matters Although no injuries have been reported yet, the FDA warns that prolonged consumption of contaminated cinnamon can cause lead accumulation in the body. Children are especially at risk, since lead exposure can impact neurological development. Cinnamon is often used in foods like cereals, baked goods, and snack mixes — staples in many households with kids. This makes the recall a major public health concern for families nationwide, including those in West Virginia, Ohio, and Pennsylvania. FDA’s Broader Effort This recall is part of a larger FDA initiative to monitor imported spices more closely. Several cinnamon brands have been flagged in prior alerts, and surveillance is ongoing. For example: The FDA recently added Asli brand ground cinnamon to the list of affected products after new testing revealed unsafe lead levels. Additional products may be named as investigations continue. See the expanded FDA alert. What You Should Do If you purchased ground cinnamon recently: Check your spice cabinet against the recall list. Dispose of any recalled products immediately. Do not repurchase affected brands until the FDA clears them. If you suspect your child or another family member has been exposed, consult a healthcare provider for guidance. For ongoing updates, visit the FDA’s cinnamon recall page. Protecting Consumers This recall is a reminder that product safety issues extend beyond toys, appliances, and vehicles — even everyday food staples can carry risks. Families in WV, OH, and PA should stay informed about recalls and understand their rights if a defective or dangerous product causes harm. At Bordas & Bordas, our attorneys help consumers hold corporations accountable when safety takes a backseat to profit.